Licking cancer: U.S. postal stamp helped fund key breast study

Countless breast cancer patients in the future will be spared millions of dollars of chemotherapy thanks in part to something that millions of Americans did that cost them just pennies: bought a postage stamp. Proceeds from the U.S. Postal Service’s breast cancer stamp put researchers over the top when they were trying to get enough money to do the landmark study published on Sunday that showed genetic testing can reveal which women with early-stage breast cancer need chemo and which do not.

Read more from Bill Clinton…

Yes, Virginia, Medicaid Expansion Will Harm the Poor

Last week, Virginia’s general assembly voted to expand Medicaid under the auspices of Obamacare. The commonwealth’s legislators had wisely resisted doing so for years, but four GOP state senators broke ranks to vote for this bill in exchange for a provision stipulating an anemic work requirement. The “news” media have, of course, touted this betrayal as a victory for the poor. It is however, precisely the reverse. Expansion will consign thousands of truly poor and disabled Virginians to purgatorial Medicaid waiting lists while advancing able-bodied adults with incomes above the federal poverty level (FPL) to the front of the line.

Why would Virginia pursue such an obviously unjust policy? Like all Democratic programs, it’s about power and money. Obamacare incentivizes expansion states to shift Medicaid’s focus to able-bodied adults by paying over 90 percent of their coverage costs, while the federal share of costs for traditional Medicaid patients remains below 60 percent. This does not mean, however, that doctors and hospitals will receive more money. Providers will continue to be paid less by Medicaid than the cost of treatment whether the patients are expansion or traditional enrollees. The extra money will go to political slush funds and insurance companies.

Medicaid expansion doesn’t work like the original program, which was administered by the states as a safety net for poor children, pregnant women, the disabled, and the elderly. Management of Obamacare’s corrupted version of the program is farmed out to insurance companies. A typical example is Wellcare, which accrued over $10.6 billion in 2017 from its coverage of able-bodied adults. The company plans to reinvest $2.5 billion of that revenue in the acquisition of Meridian Health Plans of Illinois and Michigan, which will increase its Medicaid portfolio by 37 percent. Meanwhile, truly poor patients die on waiting lists.

This is not conjecture. A recent study, conducted by the Foundation for Government Accountability (FGA), revealed that at least 21,904 Americans have withered away and died on Medicaid waiting lists in the states that expanded the program under Obamacare. Even worse, the 21,904 figure reported in the study almost certainly understates the true death toll. A number of expansion states were somehow “unable” to provide FGA with death totals, while others implausibly claimed that there were none to report. It is nonetheless clear that Medicaid waiting lists in expansion states constitute a kind of death row for the genuinely poor.

The worst carnage has occurred just north of the Beltway. Maryland is easily the deadliest state for traditional Medicaid applicants, chalking up no fewer than 8,495 deaths among individuals languishing on its waiting list. During the same time period, even as these patients were left to die, the bureaucrats of the Old Line State enrolled very nearly 300,000 able-bodied adults under the aegis of Obamacare. Louisiana took second place in killing its traditional Medicaid patients. The Pelican State reported 5,534 deaths among the unfortunates who wound up on its waiting list, while 451,000 able-bodied adults were enrolled under Obamacare’s expansion.

Additional states whose Medicaid waiting lists have killed a thousand or more people include New Mexico, where 2,031 poor and disabled patients died while the state signed up 259,537 enrollees under Obamacare’s expansion scheme. Michigan left 1,970 of its residents to die while enrolling 665,057 in its new and improved Medicaid program. West Virginia allowed 1,093 patients to die on its waiting list while signing up 181,105 able-bodied enrollees. The remaining expansion states are mere also-rans with death tolls ranging from Iowa’s paltry 989 down to Minnesota, which managed to leave only 15 of its poor and disabled citizens for dead.

This is the august company Virginia’s General Assembly chose to join last week. The Old Dominion will become the 33rd state to take Obamacare’s Medicaid expansion bait, demonstrating that the commonwealth’s politicians have learned little or nothing from the deadly experiences of the previous states that were gaffed by their own greed. Those Medicaid expansion states still have nearly 250,000 poor, disabled, and elderly individuals wasting away on waiting lists. Yet Obamacare advocates in Utah, Idaho, and Nebraska — blissfully unaware of the death tolls quoted above — are working to pass expansion in November via referenda.

Maine activists have already tricked the voters of the Pine Tree State into passing a referendum approving expansion, but the program hasn’t been implemented because Governor Paul Lepage has refused to go forward: “My administration will not implement Medicaid expansion until it has been fully funded by the Legislature at the levels DHHS has calculated, and I will not support increasing taxes on Maine families.” This speaks to one of expansion’s most profound ironies. Even if Washington continues footing most of the bill, herding the able-bodied into Medicaid is a budget buster for the states. It nearly broke Maine the last time they tried it.

Medicaid expansion under Obamacare privileges able-bodied adults with incomes above FPL, states can’t pay for it in the long haul, and it causes the genuinely poor to be dumped onto waiting lists where they quietly die in their thousands. Yet the Old Dominion’s newly-minted Governor, Ralph Northam, will gleefully sign an expansion bill into law this week as the leaders of his party and the media beam benevolently from on high. His name may even be uttered by the Great Mentioner as potential presidential material. For any Democrat, that’s certainly well worth a little inequity, the occasional budget deficit, and a few thousand human sacrifices.

The post Yes, Virginia, Medicaid Expansion Will Harm the Poor appeared first on The American Spectator.

Read more from The American Spectator…

Many breast cancer patients can skip chemo, biga

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic Many breast cancer patients can skip chemo, big study finds Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic Check out this story on yorkdispatch.com: In this Thursday, May 24, 2018 photo, Adine Usher, 78, meets with breast cancer study leader Dr. Joseph Sparano at the Montefiore and Albert Einstein College of Medicine in the Bronx borough of New York.

Read more from New York University…

Children’s Hospital of Philadelphia Celebrates 22nd Annual Fetal Surgery Family Reunion

Yearly event gathers patients and families who were treated in the Center for Fetal Diagnosis and Treatment PHILADELPHIA, June 3, 2018 /PRNewswire/ — Today, more than 2,000 people, including patients and families from over 22 states, found an important …

Read more from Children Hospital…

“Exuberance!” Soars Above Kentucky Children’s Hospital

UK is the University for Kentucky. At UK, we are educating more students, treating more patients with complex illnesses and conducting more research and service than at any time in our 150-year history. To read more about the UK story and how you can …

Read more from Children Hospital…

Many Breast Cancer Patients Can Skip Chemo, Study Finds

(From AP News)

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk.

The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs.

“The impact is tremendous,” said the study leader, Dr. Joseph Sparano of Montefiore Medical Center in New York. Most women in this situation don’t need treatment beyond surgery and hormone therapy, and “the rest of them are receiving chemotherapy unnecessarily.”

The study was funded by the National Cancer Institute, some foundations and proceeds from the U.S. breast cancer postage stamp.

Click here for article.

Read more from Against Crony Capitalism…

Wicker Introduces Pro-Life Legislation to Save Human Embryos

Miss. Senator Says, ‘Human Life Should Never Be Created or Destroyed for Research.’ U.S. Senator Roger Wicker, R-Miss., today introduced S. 2956, the “Patients First Act,” which would promote stem cell research without the creation, use …

Read more from Pro-Life Legislation…

Delivering Standardized Care May Reduce Racial Disparities in Diabetes-Associated Complications

Although kidney problems related to type 2 diabetes disproportionately affect blacks, when black and white individuals received comparable diabetes care within the context of a clinical trial, black race was not associated with faster development or progression of chronic kidney disease . The findings, which appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology , suggest that delivering standardized care to patients with type 2 diabetes may reduce racial disparities in diabetes-associated complications.

Read more from White American…